This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Sl Vaxigen, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Yong Bok Seo: Innovator in Vaccine Adjuvants
Introduction
Yong Bok Seo is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of immunology, particularly in the development of vaccine adjuvants. His innovative work aims to enhance immune responses, which is crucial for effective vaccination.
Latest Patents
Yong Bok Seo holds a patent for a novel vaccine adjuvant. This adjuvant is designed to stimulate a T lymphocyte-specific immune response. It includes an IL-12 protein and an IL-21 protein as active ingredients, or alternatively, the polynucleotides encoding these proteins. This advancement has the potential to improve vaccine efficacy significantly.
Career Highlights
Seo is associated with Sl Vaxigen, Inc., where he continues to push the boundaries of vaccine research. His work is characterized by a commitment to enhancing public health through innovative solutions. With a focus on immunological responses, he has positioned himself as a key figure in the field.
Collaborations
Yong Bok Seo collaborates with notable colleagues, including Youngwoo Choi and Sang Hee Sim. These partnerships foster a dynamic research environment that encourages the exchange of ideas and expertise.
Conclusion
Yong Bok Seo's contributions to vaccine adjuvant technology represent a significant advancement in immunology. His innovative approach and dedication to research continue to pave the way for future developments in vaccine efficacy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile